Zusammenfassung
Bei den 22.160 Patienten, die 2013 in Deutschland wegen eines Prostatakarzinoms durch eine Prostatektomie behandelten wurden, werden die direkten und indirekten Kosten einer postoperativen Harninkontinenz auf etwa/mindestens 71,6 Mio. € geschätzt. Sie übertreffen die Kosten der Operation von etwa 69,8 Mio. € erheblich. Diese volkswirtschaftliche Zusatzbelastung ist insofern beeinflussbar, als der Funktionserhalt des Harnröhrenschließmuskels von der Eingriffstechnik des Operateurs entscheidend abhängt.
Abstract
In the 22,160 patients treated in Germany for prostate cancer by prostatectomy, the costs for direct and indirect sequelae as the result of postoperative urinary incontinence are estimated to be 71.8 million €. This greatly exceeds the costs of 69.8 million € for the operation itself. This additional economic burden can, however, be decisively influenced by using a surgical technique that preserves the integrity of the urethral sphincter.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Arai Y, Kaiho Y, Takei M et al (2009) Burden of male stress urinary incontinence: a survey among urologists in Japan. Int J Urol 16:915–917
Cooperberg MR, Master VA, Carroll PR (2003) Health related quality of life significance of single pad urinary incontinence following radical prostatectomy. J Urol 170:512–515
Coyne KS, Kvasz M, Ireland AM et al (2012) Urinary incontinence and its relationship to mental health and health-related quality of life in man and women in Sweden, the United Kingdom, and the United States. Eur Urol 61:88–95
Fourcade RO, Benedict A, Black LK et al (2010) Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK. BJU Int 105:49–56
Hampel C, Artibani W, Espuna Pons M et al (2004) Understanding the burden of stress urinary incontinence in Europe: a qualitity review of the literature. Eur Urol 46:15–27
Jayadevappa R, Schwarzt JS, Chhatre S et al (2010) The burden of out-of-pocket and indirect costs of prostate cancer. Prostate 70:1255–1264
Klotz T, Brüggenjürgen B, Burkart M, Resch A (2007) The economic costs of overactive bladder in Germany. Eur Urol 51:1654–1662
Krahn MD, Zagorski B, Laporte A et al (2010) Healthcare costs associated with prostate cancer: estimates from a population-based study. BJU Int 105:338–346
Lent V, Schultheis HM, Strauß L et al (2013) Belastungsinkontinenz nach Prostatektomie in der Versorgungswirklichkeit. Urologe 52:1104–1109
Luengo-Fernandez R, Leal J, Gray A, Sullivan R (2013) Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14:1165–1174
Milsom I, Coyne KS, Nicholson S et al (2014) Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol 65:79–95
Nam RK, Herschorn S, Loblaw DA et al (2012) Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancer. J Urol 188:502–506
Rencz F, Brodszky V, Varga P et al (2014) The economic burden of prostate cancer. A systematic literature overview of registry-based studies. Orv Hetil 155:509–520
Roehrborn CG, Black LK (2011) The economic burden of prostate cancer. BJU Int 108:806–813
Soerjomataram I, Lortet-Tieulent J, Parkin DM et al (2012) Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380:1840–1850
Skolarus TA, Zhang Y, Miller DC et al (2010) The economic burden of prostate cancer survivorship care. J Urol 184:532–538
Stokes ME, Ishak J, Proskorovsky I et al (2011) Lifetime economic burden of prostate cancer. BMC Health Serv Res 11:349
Tang DH, Colayco DC, Khalaf KF et al (2014) Impact of urinary incontinence on healthcare resource utilisation, health-related quality of life and productivity in patient with overactive bladder. BJU Int 113:484–491
Wagner TH, Hu TW (1998) Economic costs of urinary incontinence in 1995. Urology 51:355–361
Einhaltung ethischer Richtlinien
Interessenkonflikt. V. Lent und H.M Schultheis geben an, dass ein Interessenkonflikt nicht besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lent, V., Schultheis, M. Volkswirtschaftliche Bedeutung der postoperativen Harninkontinenz. Urologe 54, 1564–1568 (2015). https://doi.org/10.1007/s00120-015-3856-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-015-3856-6
Schlüsselwörter
- Prostatektomie
- Prostatakarzinom
- Harnröhrenschließmuskel
- Belastungsharninkontinenz
- Prostatovesikulektomie, retropubische